We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

23 hedge funds and large institutions have $10.7M invested in ImmuCell in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

101% more capital invested

Capital invested by funds: $5.31M → $10.7M (+$5.36M)

21% more funds holding

Funds holding: 19 → 23 (+4)

9.52% more ownership

Funds ownership: 13.78% → 23.3% (+9.5%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.88M
2
AC
Antara Capital
New York
+$750K
3
WC
Wexford Capital
Florida
+$642K
4
HPC
HM Payson & Co
Maine
+$368K
5
CH
CVI Holdings
Delaware
+$71.4K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$116K
2
PCM
Perritt Capital Management
Illinois
-$9.28K
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.57K
4
Bank of America
Bank of America
North Carolina
-$29
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$4.34M +$4.88M +683,334 New
HA
2
Heartland Advisors
Wisconsin
$1.27M – – –
PCM
3
Perritt Capital Management
Illinois
$972K -$9.28K -1,300 -0.8%
AC
4
Antara Capital
New York
$666K +$750K +105,000 New
ISL
5
Ingalls & Snyder LLC
New York
$581K – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$580K -$3.57K -500 -0.5%
WC
7
Wexford Capital
Florida
$572K +$642K +90,000 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$496K +$1.83K +256 +0.3%
HPC
9
HM Payson & Co
Maine
$327K +$368K +51,500 New
SRC
10
Shufro Rose & Co
New York
$322K – – –
EFS
11
Essex Financial Services
Connecticut
$133K – – –
MA
12
Minerva Advisors
Pennsylvania
$93K – – –
Morgan Stanley
13
Morgan Stanley
New York
$88K +$8.53K +1,195 +9%
RC
14
RBF Capital
California
$83K – – –
CH
15
CVI Holdings
Delaware
$64K +$71.4K +10,000 New
UBS Group
16
UBS Group
Switzerland
$25K – – –
Bank of America
17
Bank of America
North Carolina
$19K -$29 -4 -0.1%
FHA
18
Flagship Harbor Advisors
Massachusetts
$19K – – –
BlackRock
19
BlackRock
New York
$9K – – –
Citigroup
20
Citigroup
New York
$6K – – –
TRCT
21
Tower Research Capital (TRC)
New York
$5K +$1.24K +173 +32%
Northwestern Mutual Wealth Management
22
Northwestern Mutual Wealth Management
Wisconsin
$1K +$1.08K +152 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
– -$116K -16,457 Closed

ICCC Hedge Fund Activity: Q1 2019 in Review

23 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2019, worth a combined $10.7M — up 101% from $5.31M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ICCC positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $4.88M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $116K sold.

  • 23 institutional investors held ImmuCell (ICCC) as of Q1 2019, up from 19 in Q4 2018.
  • Funds reported $10.7M of ImmuCell stock for Q1 2019, up 101% quarter-over-quarter.
  • 6 funds opened new ImmuCell positions in Q1 2019 and 2 closed out, a net change of +4 holders.
  • The largest ImmuCell buyer in Q1 2019 was Wellington Management Group, an estimated $4.88M added.
  • The largest ImmuCell seller in Q1 2019 was Susquehanna International Group, an estimated $116K sold.

Based on aggregated 13F filings for Q1 2019.